Abiopharma

(85% Positive) Cardinal Health Inc (CAH) Reports Q1 2026 Financial Results

BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference Presentation

(99% Neutral) Milestone Pharmaceuticals Inc (MIST) Announces Business Combination

New Form QUALIF - Regen BioPharma Inc Filed: 2026-01-12 AccNo: 9999999994-26-000013 Size: 1 KB

New Form EFFECT - SciSparc Ltd. Filed: 2026-01-12 AccNo: 9999999995-26-000145 Size: 1 KB

New Form 424B3 - Mitesco, Inc. Filed: 2026-01-13 AccNo: 0001185185-26-000117 Size: 1 MB

Grey symbol attribute type Security_Name was changed. Previous value: CLIENTELE LTD. New value: DYNATRONICS CORP.

Mandatory Cash Dividend/ Distribution:

General Announcement: Press release

Financial Statements and Related Announcement: Half Yearly Results

Labeling changes approved for VISTAPHARM LLC. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Labeling changes approved for HIKMA. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Labeling changes approved for NOVEL LABS INC. Active ingredient: OXYCODONE HYDROCHLORIDE. Decision date: 01/06/2026

Labeling changes approved for ABHAI LLC. Active ingredient: METHYLPHENIDATE HYDROCHLORIDE. Decision date: 01/09/2026